GenSight Biologics S.A.

SIGHT.PA·Paris·Healthcare
Compare
0.0702+0.0010 (+1.45%)today
As of Nov 5, 12:59 PM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.0692
Open0.0710
Day range0.06900.0727
52-week range0.06000.1490
Off day high−3.44%
Off 52-week high−52.89%
Volume249.37K
Avg. volume (3M)1.73M
Market cap17.22M
EPS (TTM)-0.0800
Forward P/E-0.09
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.69
Shares outstanding245.28M
Short interest—
Earnings dateSep 19, 2025
Analyst target0.3050
Profit margin0.00%

Against its peers

Compare in full ›
SIGHT.PA OCGN IRD EYPT MGTX LCTX
Market cap 17.22M 296.55M 355.25M 33.12M 904.72M 260.49M
P/E (TTM) — — — — 10.8 —
Forward P/E -0.1 -3.5 -6.0 -0.2 -6.2 -7.5
Price/book -0.5 -16.8 -27.2 0.2 4.1 4.3
Dividend yield — — — — — —
1-year change −48.74% −36.59% +110.34% −96.39% +12.01% −40.46%
Today +1.45% +17.35% +8.65% −1.23% −1.05% +1.98%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All SIGHT.PA news ›
MarketScreener·Negative

GenSight Biologics S.A. Auditor Raises 'Going Concern' Doubt

GenSight Biologics S.A. filed its Annual on Apr 15, 2026 for the period ending Dec 31, 2025. In this report its auditor, BECOUZE,Deloitte & Associés, gave an unqualified opinion expressing doubt that... Biotechnology & Medical Research…

MarketScreener·Positive

Gensight Biologics Announces Executive Changes

GenSight Biologics announced the strategic expansion of its Regulatory Affairs & Quality department with two senior appointments following recent regulatory milestones. The company named Fang Li,... GenSight Biologics announced the…

MarketScreener·Positive

GenSight Biologics Closes EUR1.7 Million Fundraising

GenSight Biologics secured 1.7 million euros from a recently closed fundraising subscribed by three of its shareholders, according to a Wednesday release. The French clinical-stage biotechnology... Biotechnology & Medical Research GenSight…

From the 4Search news index, newest first.

In the news

10mentions in 30 days
10with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 10 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance